KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Debt Ratio (2020 - 2025)

Historic Debt Ratio for Regeneron Pharmaceuticals (REGN) over the last 6 years, with Q4 2025 value amounting to 0.05.

  • Regeneron Pharmaceuticals' Debt Ratio fell 683.15% to 0.05 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.05, marking a year-over-year decrease of 683.15%. This contributed to the annual value of 0.05 for FY2025, which is 683.15% down from last year.
  • Regeneron Pharmaceuticals' Debt Ratio amounted to 0.05 in Q4 2025, which was down 683.15% from 0.05 recorded in Q3 2025.
  • Over the past 5 years, Regeneron Pharmaceuticals' Debt Ratio peaked at 0.11 during Q1 2021, and registered a low of 0.05 during Q4 2025.
  • In the last 5 years, Regeneron Pharmaceuticals' Debt Ratio had a median value of 0.06 in 2023 and averaged 0.07.
  • In the last 5 years, Regeneron Pharmaceuticals' Debt Ratio crashed by 3249.89% in 2022 and then crashed by 550.8% in 2025.
  • Over the past 5 years, Regeneron Pharmaceuticals' Debt Ratio (Quarter) stood at 0.08 in 2021, then dropped by 12.88% to 0.07 in 2022, then decreased by 11.62% to 0.06 in 2023, then decreased by 12.33% to 0.05 in 2024, then decreased by 6.83% to 0.05 in 2025.
  • Its Debt Ratio was 0.05 in Q4 2025, compared to 0.05 in Q3 2025 and 0.05 in Q2 2025.